Accretion Nutraveda
ANLBSE

Accretion Nutraveda

₹286.000.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
286.00
Today’s high
292.95
52 week low
150.10
52 week high
305.00
Open price
292.95
Previous close
286.00
Live volume
--
Lower circuit
228.80
Upper circuit
343.20

Fundamentals

Market Cap
₹201Cr
ROE
14.29%
P/E Ratio(TTM)
0.00
EPS(TTM)
0.00
P/B Ratio
5.65
Dividend Yield
0.00%
Industry P/E
50.40
Book Value
49.00
Debt to Equity
0.12
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2026
Revenue (Cr)
₹33.72
+110.62%
Profit (Cr)
₹5.07
+102.66%
010203040
2023
2024
2025
2026
Revenue growthValue
3Y CAGR+122%
Profit growthValue
3Y CAGR+162%

About

Accretion Nutraveda functions as a CDMO (Contract Development and Manufacturing Organisation). It combines traditional Ayurvedic principles with modern nutraceutical science to serve both domestic and international markets.;
CEO/MD
Mayur Popatlal Sojitra
Founded in
2021
BSE symbol
544694

Shareholding pattern

Sep '25
Jan '26
Feb '26
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,978.20
0.00 (--)
L
    H
    22,759.9530.965.42
    ₹2,560.80
    0.00 (--)
    L
      H
      19,444.5528.685.42
      ₹7,415.50
      0.00 (--)
      L
        H
        18,526.25109.2221.23
        Natco PharmaNATCOPHARM
        ₹882.40
        0.00 (--)
        L
          H
          15,806.4513.811.71
          2026
          8
          May
          Annual Result
          Release date
          Events calendar
          View upcoming events in other stocks